文献速递主动脉疾病

腹主动脉瘤腔内修复术后非家庭出院的相关因素

Factors associated with nonhome discharge after endovascular aneurysm repair.
PubMed 文献 · J Vasc Surg · 2024-09-03

基于血管质量倡议(2003-2022)61,792例择期腹主动脉瘤腔内修复(EVAR)患者,3155例(5.1%)发生非家庭出院(NHD)。多因素分析显示年龄、女性、动脉瘤直径>65mm及贫血、慢阻肺、心衰、体重、糖尿病与NHD风险升高相关;阿司匹林、他汀、ACEI/ARB使用与风险降低相关。NHD与5年死亡率升高相关(40% vs 14%;校正HR 2.13)。

要点

  • 择期EVAR后NHD发生率为5.1%(3155/61,792)。
  • 年龄每增加10岁OR 2.15、女性OR 1.79、动脉瘤直径>65mm OR 2.18与NHD风险升高相关。
  • NHD与5年死亡率升高相关(40% vs 14%;校正HR 2.13,95%CI 1.86-2.44)。

核心结论

  • 多个术前因素与择期EVAR后NHD风险升高相关,包括不可改变因素(女性、较大主动脉直径)和可能可改变因素(贫血、慢阻肺、心衰、体重指数、糖尿病)。
  • 作者认为应对存在不可改变因素的人群给予特别关注,并认为优化与较高NHD可能性相关的医疗状况似乎是合适的,以改善EVAR后的患者结局和生活质量。

研究设计与样本

  • 回顾性队列研究,使用血管质量倡议(Vascular Quality Initiative)2003-2022年全国数据,纳入接受择期EVAR的成年患者,排除术前非家庭居住者,最终纳入61,792例。
  • 采用多因素logistic回归识别与NHD相关的术前因素;采用Kaplan-Meier法和Cox回归分析评估NHD对5年生存的影响作为次要结局。

主要发现

  • NHD患者3155例(5.1%),NHD患者更可能年龄较大(79岁[四分位距73-18岁] vs 73岁[四分位距67-79岁])、女性(33.7% vs 18.2%;P < .001)、非白人(16.0% vs 11.7%;P < .001)且合并症更多。
  • NHD患者术后并发症发生率更高:急性肾损伤11.9% vs 2.0%(P < .001)、心肌梗死3.8% vs 0.5%(P < .001)、院内再干预4.7% vs 0.5%(P = .033)。
  • 多因素分析显示与NHD风险升高相关的术前因素包括:年龄(每增加10岁:OR 2.15;95%CI 2.03-2.28;P < .001)、女性(OR 1.79;95%CI 1.63-1.95;P < .001)、动脉瘤直径>65 mm(OR 2.18;95%CI 1.98-2.39;P < .001),以及贫血、慢阻肺、慢性心衰、体重和糖尿病。
  • 阿司匹林、他汀和血管紧张素转换酶抑制剂/血管紧张素II受体阻滞剂使用与NHD风险降低相关。
  • NHD与5年死亡率升高相关(40% vs 14%;校正HR 2.13;95%CI 1.86-2.44;P < .001)。

关键数值与推荐

  • 年龄每增加10岁与NHD风险升高相关(OR 2.15;95%CI 2.03-2.28;P < .001)。
  • 女性与NHD风险升高相关(OR 1.79;95%CI 1.63-1.95;P < .001)。
  • 动脉瘤直径>65 mm与NHD风险升高相关(OR 2.18;95%CI 1.98-2.39;P < .001)。
  • NHD与5年死亡率升高相关(40% vs 14%;校正HR 2.13;95%CI 1.86-2.44;P < .001)。

临床怎么用

  • 作者认为应对存在不可改变因素(女性、较大主动脉直径)的人群给予特别关注。
  • 作者认为优化与较高NHD可能性相关的医疗状况似乎是合适的,以改善EVAR后的患者结局和生活质量。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aims to identify preoperative factors associated with nonhome discharge (NHD) after endovascular aneurysm repair (EVAR). NHD has implications for patient care, readmission, and long-term mortality; nevertheless, the existing literature lacks information regarding factors associated with NHD for patients undergoing EVAR. In contrast, our study assesses preoperative factors associated with NHD for this population by using national data from the Vascular Quality Initiative. METHODS: We identified adult patients who underwent elective EVAR in the Vascular Quality Initiative (2003-2022) and excluded those who were not living at home preoperatively. Multivariable logistic regression was used to identify preoperative factors associated with NHD. Kaplan-Meier methods and Cox-regression analyses were used to assess the impact of NHD on 5-year survival as a secondary outcome. RESULTS: We included 61,792 patients, of which 3155 (5.1%) had NHD. NHD patients were more likely to be older (79 years [interquartile range, 73-18 years] vs 73 years [interquartile range, 67-79 years]), female (33.7% vs 18.2%; P < .001), non-White (16.0% vs 11.7%; P < .001), and have more comorbidities. NHD patients had higher rates of postoperative complications (acute kidney injury, 11.9% vs 2.0% [P < .001]; myocardial infarction, 3.8% vs 0.5% [P < .001]; and in-hospital reintervention, 4.7% vs 0.5% [P = .033]). Multivariable analysis revealed many preoperative characteristics were associated with higher odds of NHD: most notably, age (per additional decade: odds ratio [OR], 2.15; 95% confidence interval [CI], 2.03-2.28; P < .001), female sex (OR, 1.79; 95% CI, 1.63-1.95; P < .001) and aneurysm diameter >65 mm (OR, 2.18; 95% CI, 1.98-2.39; P < .001), along with potentially modifiable factors, including anemia, chronic obstructive pulmonary disease, chronic heart failure, weight, and diabetes. In contrast, aspirin, statin, and angiotensin-converting enzyme inhibitor/angiotensin II receptor blocekr use were associated with lower odds of NHD. NHD was associated with higher hazards of 5-year mortality, even after adjusting for confounders (40% vs 14%; adjusted hazard ratio, 2.13; 95% CI, 1.86-2.44; P < .001). CONCLUSIONS: Several factors were associated with higher odds of NHD after elective EVAR, including nonmodifiable factors such as female sex and larger aortic diameter, and potentially modifiable factors such as anemia, chronic obstructive pulmonary disease, chronic heart failure, body mass index, and diabetes. Special attention should be given to populations with nonmodifiable factors, and efforts at optimizing medical conditions with higher NHD likelihood seems appropriate to improve patient outcomes and quality of life after EVAR.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Straus S, Gomez-Mayorga JL, Sanders AP, et al. Factors associated with nonhome discharge after endovascular aneurysm repair. J Vasc Surg. 2024. PMID: 39237060. doi:10.1016/j.jvs.2024.08.060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。